The most common adverse events were gastrointestinal and dose-related: diarrhea (27.4% / 33.5% / 33.6% at 4 / 9 / 12 mg vs 13.2% on placebo), nausea (13.7% / 20.8% / 28.0% vs 8.0%) and constipation (14.0% / 16.2% / 16.8% vs 9.4%)
Abrahamsson N, Borjesson JL, Sundbom M, Wiklund U, Karlsson FA, Eriksson JW
This is where the HypothalamicPituitaryOvarian (HPO) axis comes in
Both compounds arrived at a unique moment in weight management history
Timeline of Retatrutide Results: Week by Week The trial data shows weight loss beginning early and continuing throughout treatment
The co-infusion of PYY(3-36) and GLP-1 led to a synergistic effect with near-suppression of these areas, correlating with the suppression in appetite as assessed by food intake studies [42]